FDA gets 5,000 Chantix complaints


Talk about an outpouring of adverse-event reports. After WFAA-TV in Dallas reported musician Carter Albrecht's violent death--perhaps under the influence of Pfizer's smoking-cessation drug Chantix--more than 5,000 complaints about the med's side effects poured into the FDA. And the complaints were serious: 55 reported suicide, 199 reported suicidal thoughts, and 417 complained of depression, according to the TV station, which obtained the reports. Hundreds of others mentioned anger, aggression, amnesia, hallucinations, and homicidal thoughts.

You'll recall that the FDA announced last week that it would investigate Chantix's safety after reports of psychiatric side effects, including one instance of "erratic" behavior. That apparently was Albrecht, who ranted and raved at a neighbor's door until the neighbor shot him. An FDA spokesperson told WFAA that it is looking into 100 "specific psychotic incidents" in the U.S. The agency also said it had already intended to investigate the drug because of complaints in Europe when news of Albrecht's death broke.

Related Articles:
'Erratic' behavior triggers Chantix probe. Report
Chantix outperforms Zyban in major study. Report
Addex smoking cessation drug misses endpoint. Report

Suggested Articles

Life sciences companies have pivoted quickly during COVID-19 - Syneos Health® is supporting more than 80 active COVID-19 projects, including vaccines.

New York's Covaxx has signed on with three South American nations to provide 140 million doses of its early-stage COVID-19 vaccine.

To get the COVID-19 vaccine out quickly, Pfizer has been running rehearsals at distribution sites, creating "growing confidence," U.S. officials said.